ACBM · Acro Biomedical Co., Ltd. · Analyst Estimates
$0.03
At close · Sep 7
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of the financial statements being issued. In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2025, financial statements, has expressed substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.56M
Shares
60.04M
Volume · Sep 7
66
Avg daily vol (2 sessions)
163
Analyst Estimates
Compare analyst forecasts for Acro Biomedical Co., Ltd. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
This verified capture contains no analyst forecast observations. Older snapshots remain in the history.
Captured 2026-09-18 08:03 UTC · Publication dates shown per estimate · 0 metric / period groups